chr19-12035555-T-C

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_001308348.2(ZNF433):c.-16A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The gene ZNF433 is a tumor suppressor gene (CancerMine: 1 TSG, 1 driver citations). The gene ZNF433 is a cancer driver gene (CancerMine: 1 TSG, 1 driver citations). The variant allele was found at a cumulative frequency of 0.0387 (AC=60,731) in the gnomAD database across 1,569,724 control chromosomes, including 1,832 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.159. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.070 ( 613 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1219 hom. )

Consequence

ZNF433
NM_001308348.2 5_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.335

Publications

32 publications found
Variant links:
Genes affected
ZNF433 (HGNC:20811): (zinc finger protein 433) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001308348.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.159 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001308348.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ZNF433 NM_001308348.2
MANE Select
HGVSc / HGVSpc.-16A>G
Exon rankExon 1 of 4
5_prime_UTR
Prot: NP_001295277.1UniProt: F8VTV7
ZNF433 NM_001080411.3
HGVSc / HGVSpc.-16A>G
Exon rankExon 1 of 4
5_prime_UTR
Prot: NP_001073880.1UniProt: Q8N7K0-1
ZNF433 NM_001308346.2
HGVSc / HGVSpc.-78A>G
Exon rankExon 1 of 5
5_prime_UTR
Prot: NP_001295275.1UniProt: F8W0C9

Ensembl Transcripts

ZNF433 ENST00000550507.7
TSL:2MANE Select
HGVSc / HGVSpc.-16A>G
Exon rankExon 1 of 4
5_prime_UTR
Prot: ENSP00000448099.2UniProt: F8VTV7
ZNF433 ENST00000419886.7
TSL:1
HGVSc / HGVSpc.-159A>G
Exon rankExon 1 of 5
5_prime_UTR
Prot: ENSP00000393416.2UniProt: Q8N7K0-2
ENSG00000286098 ENST00000652448.1
HGVSc / HGVSpc.-94+33733T>C
Exon rankIntron 2 of 4
intron
Prot: ENSP00000498410.1UniProt: A0A494C069

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0704
AC:10700
Hom:609
AN:152080
Cov:32
GnomAD2 exomes
AF: 0.0401
AC:7179
AN:178944
GnomAD4 exome
AF: 0.0353
AC:50015
Hom:1219
AN:1417526
Cov:31
GnomAD4 genome
AF: 0.0704
AC:10716
Hom:613
AN:152198
Cov:32
TOPMed (Bravo)
AF: 0.0723
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0445
AC:15475
Hom:563
AN:347684
Local & regional cohorts 11 sources
ABraOM SABE-WGS-1171
AF: 0.0692
AC:162
Hom:8
AN:2342
ChinaMAP Phase 1
AF: 0.0216
Denmark Genome
AF: 0.0367
AC:11
AN:300
ESP6500 (Exome Variant Server)
AF: 0.0656
AC:814
AN:12402
GenomeAsia100K
AF: 0.0300
AC:104
AN:3478
Korea4K (4,157 Koreans)
AF: 0.0280
AC:203
AN:7222
Qatari Genome
AF: 0.0795
AC:14
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0244
AC:2986
Hom:33
AN:122334
Turkish Variome
AF: 0.0399
AC:263
Hom:8
AN:6588
UK10K
AF: 0.0337
AC:255
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0224
AC:201
Hom:2
AN:8960
Showing 17 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.0320 90928414 0.0324 93328828
SCHEMA
(Schizophrenia)
0.0785 8764111642 0.0774 14519187676
Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign9.7
BayesDel_noAF
Benign-0.81
CADD
Benign7.7
DANN
Benign0.68
GPN-Star LLR
N/A-2.9
GPN-Star score
N/A2.9
Mutation Taster
N/A299/1polymorphism (auto)
PhyloP100
Benign-0.34
PromoterAI
N/A0.12Neutral
Showing 9 of 9 scores

Splicing Scores

Pangolin (max)
Benign0.060
SpliceAI score (max)
Benign0.020
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.